Effectiveness of switching between biologics in psoriatic arthritis- results of a large regional survey

Clin Med (Lond). 2014 Feb;14(1):95-6. doi: 10.7861/clinmedicine.14-1-95.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Adult
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Arthritis, Psoriatic / drug therapy*
  • Etanercept
  • Female
  • Guideline Adherence*
  • Humans
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Treatment Failure
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • United Kingdom

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • golimumab
  • Infliximab
  • Adalimumab
  • Etanercept